By MATTHEW PERRONE, Associated Press
WASHINGTON (AP) — The head of the Food and Drug Administration plans to start offering bonus payments to agency drug reviewers who complete their work ahead of schedule, the latest in a flurry of changes to longstanding norms and procedures.
FDA Commissioner Marty Makary described the effort as a pilot program during a staff presentation Thursday, saying the first quarterly bonus payments would start going out to employees around August. The Associated Press obtained slides and a recording of the presentation.
“My job as your commissioner is to be your advocate and to fight for you,” Makary told FDA staffers, adding that getting approval for the payments took “some wrangling.”
“If you don’t like it, we can get rid of it, but usually everybody loves money,” Makary said.

1 week ago
4














English (US) ·